DNA methylation in mammalian development and disease.
Abstract
The DNA methylation field has matured from a phase of discovery and genomic characterization to one seeking deeper functional understanding of how this modification contributes to development, ageing and disease. In particular, the past decade has seen many exciting mechanistic discoveries that have substantially expanded our appreciation for how this generic, evolutionarily ancient modification can be incorporated into robust epigenetic codes. Here, we summarize the current understanding of the distinct DNA methylation landscapes that emerge over the mammalian lifespan and discuss how they interact with other regulatory layers to support diverse genomic functions. We then review the rising interest in alternative patterns found during senescence and the somatic transition to cancer. Alongside advancements in single-cell and long-read sequencing technologies, the collective insights made across these fields offer new opportunities to connect the biochemical and genetic features of DNA methylation to cell physiology, developmental potential and phenotype.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper discusses DNA methylation in the context of mammalian development and disease, particularly focusing on how these modifications relate to aging and the transition to cancer. It explores the functional understanding of DNA methylation and its implications for cell physiology and developmental potential, which are relevant to the root causes of aging. However, while it presents important findings, it does not propose novel solutions or significant breakthroughs that could transform the field, thus receiving a moderate impact score.
Author of this paper? Send a correction.